Search Count: 70
 |
Organism: Homo sapiens, Hepatitis b virus
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2024-10-16 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens, Hepatitis b virus
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2024-10-16 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens, Hepatitis b virus
Method: X-RAY DIFFRACTION Resolution:2.61 Å Release Date: 2024-10-16 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2022-01-19 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: MN, XRP |
 |
Crystal Structure Of Ldha In Complex With Compound Ncgc00384414-01 At 2.05 A Resolution
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2020-09-23 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: PO4, P8M, NAI, GOL |
 |
Crystal Structure Of Ldha In Complex With Compound Ncgc00420737-09 At 2.00 A Resolution
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-09-23 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: NAI, P8V, EDO |
 |
Linked Kdm5A Jmj Domain Bound To The Potential Hydrolysis Product Of Inhibitor N45 I.E. 3-((6-(4-(2-Cyano-3-Methylbut-2-Enoyl)-1,4-Diazepan-1-Yl)-2-(Pyridin-2-Yl)Pyrimidin-4-Yl)Amino)Propanoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H6M, MN, EDO, GOL |
 |
Linked Kdm5A Jmj Domain Bound To The Inhibitor N50 I.E. 2-(4-((2-(Dimethylamino)Ethyl)(Ethyl)Carbamoyl)-5-(4-Methoxyphenyl)-1H-Pyrazol-1-Yl)Isonicotinic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H5Y, MN, DMS, GOL, SO4 |
 |
Linked Kdm5A Jmj Domain Bound To The Inhibitor N53 I.E. 2-(5-([1,1'-Biphenyl]-3-Yl)-4-(1-(2-(Piperidin-1-Yl)Ethoxy)Ethyl)-1H-Pyrazol-1-Yl)Isonicotinic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H67, MN, GOL, DMS |
 |
Linked Kdm5A Jmj Domain Bound To The Inhibitor N67 I.E. 2-(5-Phenyl-4-(Phenyl(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1H-Pyrazol-1-Yl)Isonicotinic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H6A, MN, GOL, DMS |
 |
Linked Kdm5A Jmj Domain Bound To The Inhibitor N68 I.E. 2-(1-(2-(Piperidin-1-Yl)Ethyl)-1H-Benzo[D]Imidazol-2-Yl)Thieno[3,2-B]Pyridine-7-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H61, MN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2019-04-03 Classification: PROTEIN BINDING Ligands: JBS, GOL |
 |
Crystal Structure Of Lecithin:Cholesterol Acyltransferase (Lcat) In Complex With Isopropyl Dodec-11-Enylfluorophosphonate (Idfp) And A Small Molecule Activator
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2018-12-05 Classification: transferase/transferase inhibitor Ligands: NAG, H9A, H94, SO4, NI |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.39 Å Release Date: 2018-11-21 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: K0I, MN, GOL, SO4, DMS |
 |
Linked Kdm5A Jmj Domain Bound To The Inhibitor N43 I.E. 3-((6-(4-Acryloyl-1,4-Diazepan-1-Yl)-2-(Pyridin-2-Yl)Pyrimidin-4-Yl)Amino)Propanoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2018-11-21 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H6G, MN |
 |
Linked Kdm5A Jmj Domain Bound To The Inhibitor N44 I.E. 3-((2-(Pyridin-2-Yl)-6-(4-(Vinylsulfonyl)-1,4-Diazepan-1-Yl)Pyrimidin-4-Yl)Amino)Propanoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2018-11-21 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H6J, MN, GOL, DMS |
 |
Linked Kdm5A Jmj Domain Bound To The Inhibitor N49 I.E. 2-((2-Chlorophenyl)(2-(1-Methylpyrrolidin-2-Yl)Ethoxy)Methyl)Thieno[3,2-B]Pyridine-7-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2018-11-21 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H6S, H6T, MN, DMS, SO4, EDO |
 |
Linked Kdm5A Jmj Domain Bound To The Covalent Inhibitor N69 I.E. [2-((3-Acrylamidophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)Thieno[3,2-B]Pyridine-7-Carboxylic Acid]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2018-11-21 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H74, MN, GOL, DMS, EDO |
 |
Linked Kdm5A Jmj Domain Bound To Inhibitor N70 I.E.[2-((3-Aminophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)Thieno[3,2-B]Pyridine-7-Carboxylic Acid]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2018-11-21 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H6V, MN, GOL, EDO |
 |
Linked Kdm5A Jmj Domain Forming Covalent Bond To Inhibitor N71 I.E. 2-((3-(4-(Dimethylamino)But-2-Enamido)Phenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)Thieno[3,2-B]Pyridine-7-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2018-11-21 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: H77, HZV, HZM, MN, GOL, DMS |